Your session is about to expire
← Back to Search
Investigational MRI Techniques for Imaging Assessment
N/A
Waitlist Available
Led By Michael V Knopp, MD, PhD
Research Sponsored by University of Cincinnati
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Must not have
Subjects incapable of giving informed written consent
Participants that experience claustrophobia, anxiety and/or vertigo when moved inside the scanner
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1-3 years
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing different MRI techniques to see which are best for future clinical trials.
Who is the study for?
This trial is for adults who can safely undergo an MRI, including those already scheduled for a standard MRI at The Ohio State University. It's not suitable for individuals with metal implants, pacemakers, certain tattoos, or conditions that affect MRI safety; nor pregnant women, prisoners, or those unable to consent.
What is being tested?
The study is testing new ways of doing and processing MRI scans to improve the technique. Some participants will receive these investigational MRIs in addition to their standard care while others will get them separately.
What are the potential side effects?
MRIs are generally safe but may cause discomfort due to loud noises during the scan or feelings of claustrophobia. There's also a small risk of allergic reactions if contrast agents are used.
Eligibility Criteria
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am unable to understand or sign the consent form.
Select...
I feel claustrophobic, anxious, or dizzy in tight spaces like scanners.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion, an average of 1-3 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1-3 years
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Artifacts
Image noise
Image quality
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Patient populationExperimental Treatment1 Intervention
Group II: Healthy volunteer populationExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
University of CincinnatiLead Sponsor
435 Previous Clinical Trials
635,261 Total Patients Enrolled
Ohio State UniversityLead Sponsor
865 Previous Clinical Trials
654,963 Total Patients Enrolled
Michael V Knopp, MD, PhDPrincipal InvestigatorOhio State University
8 Previous Clinical Trials
427 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am unable to understand or sign the consent form.I feel claustrophobic, anxious, or dizzy in tight spaces like scanners.I am 18 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: Patient population
- Group 2: Healthy volunteer population
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger